Standout Papers

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms t... 2021 2026 2022 2024174
  1. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers (2021)
    Matteo Palmeri, Janice M. Mehnert et al. ESMO Open

Immediate Impact

52 standout
Sub-graph 1 of 24

Citing Papers

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
2024 Standout
2 intermediate papers

Works of Ryan D. Stephenson being referenced

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
2021 Standout
Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
2009

Author Peers

Author Last Decade Papers Cites
Ryan D. Stephenson 350 262 178 18 497
Spyridon Sideris 371 155 185 27 491
Jean-Christophe Eymard 343 223 88 12 471
Gary Shelton 337 194 53 14 466
Hielke J. Meulenbeld 314 280 85 17 569
Chenfei Chi 272 170 62 24 456
Eggleston Jc 320 137 104 12 557
Marie Hjälm-Eriksson 352 108 80 17 435
Hussein D. Aoun 359 160 91 21 571
Giovanna Vacca 101 227 201 20 532
Heikki Joensuu 230 158 227 11 538

All Works

Loading papers...

Rankless by CCL
2026